Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Guyton

Showing results (91-100 of 161) with videos related to

Pageof 17
Sort By:
Atherosclerosis|December 1, 1995
Toxicity of oxidized low density lipoproteins for vascular smooth muscle cells and partial protection by antioxidantsJ R Guyton, M L Lenz, B Mathews, et al.
The American Journal of Cardiology|January 13, 2004
Treating to New Targets (TNT) Study: does lowering low-density lipoprotein cholesterol levels below currently recommended guidelines yield incremental clinical benefit?David D Waters, John R Guyton, David M Herrington, et al.
Metabolism: Clinical and Experimental|October 10, 1997
Lovastatin increases exercise-induced skeletal muscle injuryP D Thompson, J M Zmuda, L J Domalik, et al.
Circulation|October 1, 1986
Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiographyG H Dahlen, J R Guyton, M Attar, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 13, 2006
Effectiveness and tolerability of adding ezetimibe to niacin-based regimens for treatment of primary hyperlipidemiaNicole E Jelesoff, Christie M Ballantyne, Antonios M Xydakis, et al.
The American Journal of Cardiology|September 18, 2004
Effectiveness and tolerability of ezetimibe add-on therapy to a bile acid resin-based regimen for hypercholesterolemiaAntonios M Xydakis, John R Guyton, Philip Chiou, et al.
Journal of Obesity|January 22, 2011
Gene by sex interaction for measures of obesity in the framingham heart studyAshlee M Benjamin, Sunil Suchindran, Kaela Pearce, et al.
Journal of Neurochemistry|March 7, 1998
Novel large apolipoprotein E-containing lipoproteins of density 1.006-1.060 g/ml in human cerebrospinal fluidJ R Guyton, S E Miller, M E Martin, et al.
Journal of Clinical Lipidology|September 1, 2016
Triglyceride-lowering therapies reduce cardiovascular disease event risk in subjects with hypertriglyceridemiaKevin C Maki, John R Guyton, Carl E Orringer, et al.
Journal of Clinical Lipidology|February 5, 2011
Lipoprotein and apolipoprotein ratios in the VYTAL trial of ezetimibe/simvastatin compared with atorvastatin in type 2 diabetesJohn R Guyton, Ronald B Goldberg, Theodore Mazzone, et al.
Pageof 17

Showing results (91-100 of 161) with videos related to

Sort By:
Pageof 17
Atherosclerosis|December 1, 1995
Toxicity of oxidized low density lipoproteins for vascular smooth muscle cells and partial protection by antioxidantsJ R Guyton, M L Lenz, B Mathews, et al.
The American Journal of Cardiology|January 13, 2004
Treating to New Targets (TNT) Study: does lowering low-density lipoprotein cholesterol levels below currently recommended guidelines yield incremental clinical benefit?David D Waters, John R Guyton, David M Herrington, et al.
Metabolism: Clinical and Experimental|October 10, 1997
Lovastatin increases exercise-induced skeletal muscle injuryP D Thompson, J M Zmuda, L J Domalik, et al.
Circulation|October 1, 1986
Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiographyG H Dahlen, J R Guyton, M Attar, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 13, 2006
Effectiveness and tolerability of adding ezetimibe to niacin-based regimens for treatment of primary hyperlipidemiaNicole E Jelesoff, Christie M Ballantyne, Antonios M Xydakis, et al.
The American Journal of Cardiology|September 18, 2004
Effectiveness and tolerability of ezetimibe add-on therapy to a bile acid resin-based regimen for hypercholesterolemiaAntonios M Xydakis, John R Guyton, Philip Chiou, et al.
Journal of Obesity|January 22, 2011
Gene by sex interaction for measures of obesity in the framingham heart studyAshlee M Benjamin, Sunil Suchindran, Kaela Pearce, et al.
Journal of Neurochemistry|March 7, 1998
Novel large apolipoprotein E-containing lipoproteins of density 1.006-1.060 g/ml in human cerebrospinal fluidJ R Guyton, S E Miller, M E Martin, et al.
Journal of Clinical Lipidology|September 1, 2016
Triglyceride-lowering therapies reduce cardiovascular disease event risk in subjects with hypertriglyceridemiaKevin C Maki, John R Guyton, Carl E Orringer, et al.
Journal of Clinical Lipidology|February 5, 2011
Lipoprotein and apolipoprotein ratios in the VYTAL trial of ezetimibe/simvastatin compared with atorvastatin in type 2 diabetesJohn R Guyton, Ronald B Goldberg, Theodore Mazzone, et al.
Pageof 17